The estimated Net Worth of Robert W.A. Sellers is at least $7.57 Million dollars as of 12 February 2024. Robert Sellers owns over 12,210 units of Edwards Lifesciences Corp stock worth over $1,726,520 and over the last 11 years Robert sold EW stock worth over $5,843,010.
Robert has made over 18 trades of the Edwards Lifesciences Corp stock since 2014, according to the Form 4 filled with the SEC. Most recently Robert exercised 12,210 units of EW stock worth $448,718 on 12 February 2024.
The largest trade Robert's ever made was exercising 21,540 units of Edwards Lifesciences Corp stock on 27 August 2020 worth over $468,710. On average, Robert trades about 3,051 units every 73 days since 2014. As of 12 February 2024 Robert still owns at least 25,297 units of Edwards Lifesciences Corp stock.
You can see the complete history of Robert Sellers stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is ONE EDWARDS WAY, , IRVINE, CA, 92614.
Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo, and Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: